Knowledge hub

News

News

Ardigen Collaborates on Breakthrough in TCR Therapy Advancements

Ardigen CEO Janusz Homa Recognized Among AI Sector Leaders by Forbes Polska
Ardigen Representatives Share Expertise with Silesian University of Technology Students
Leave Your Trace Foundation and Ardigen Unveil “ONCODecalogue of Emotions” for Children Facing Health Challenges
Hackathon – March 2023
Ardigen and DKFZ Research Groups Collaborate to Evaluate the TCR-based Therapies (TCR-Ts)
Ardigen at SLAS International Conference & Exhibition 2023
Meet Ardigen phenAID platform
Ardigen at PMWC 2023
News

Mariola Fotin-Mleczek, PhD, Has Joined Ardigen’s Scientific Board

Ardigen supports JUMP-CP Consortium – The World’s Largest Public Cell Painting Dataset
Agnieszka Blum, MD, PhD, Promoted to the Ardigen Management Board
Prof. Dr. med. Michael Schmitt, MHBA in Ardigen’s Scientific Board
Łukasz Dutkiewicz, PhD Welcomed in Ardigen as a Business Development Director
Discover Our Gene Regulation Platform
Boost Your Way to Successful Therapy: AI for Drug Discovery Days
Ardigen – New Corporate Identity
Happy Holidays 2021